Product features
Indirect chemiluminescent immunoassay (CLIA) to test antibodies against SARS-CoV-2 in human serum/plasma.
- Monotest format with ready-to-use reagents.
- Simple and automated protocol, with fast results.
- Comprehensive panel including a test to quantify antibodies against the SARS-CoV-2 spike protein
- Customizable configuration of samples and reagents according to laboratory needs.
- Each monotest includes a calibrator and a negative control, enabling individual validation and interpretation of each sample.
- Use of primary tubes, with no need for manual pipetting.
PRODUCTS
COVID-19 VIRCLIA® IgG MONOTEST
Analytes: SARS-COV-2
COVID-19 VIRCLIA® IgM+IgA MONOTEST
Analytes: SARS-COV-2
COVID-19 SPIKE QUANTITATIVE VIRCLIA® IgG MONOTEST
Analytes: SARS-COV-2
USED ON
VIRCLIA® LOTUS
A compact automated CLIA platform for VirClia® infectious disease testing, combining ready-to-use single-test flexibility with continuous random access efficiency.
MORE RESOURCES
Related germs and organisms categorized for this product line.
Downloadable PDF materials, brochures, and technical documents.
The latest insights, news, and research articles from our scientific team.
Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...
Beyond detection: H. pylori testing in today’s laboratory workflow
Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...
Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...
Scientific bibliography and references related to this product.
